Daytime sleepiness is one of the most common symptoms encountered in sleep medicine, yet recent population-level data suggest that its prevalence and functional impact may be ...
Nocturnal hypoxemia is a frequent yet under-recognized physiologic consequence of chronic obstructive pulmonary disease (COPD). Even in patients who maintain adequate oxygenation ...
Few areas of respiratory medicine have faced as much challenge as chronic obstructive pulmonary disease (COPD) drug development. Despite decades of work, COPD remains a leading ...
Artificial intelligence (AI) has progressed rapidly from concept to operative tool across respiratory and sleep medicine. The convergence of large, annotated sleep datasets, ...
Wound healing is an intricate biological process requiring the orchestration of immune, endocrine, vascular, and tissue-repair systems. Clinicians have long emphasized surgical ...
Obesity and obstructive sleep apnea (OSA) are interconnected health conditions that significantly impact quality of life and increase the risk of comorbidities such as ...
Obstructive sleep apnea (OSA) is a prevalent, yet often underdiagnosed condition characterized by repetitive episodes of partial or complete upper airway obstruction during sleep, ...
Managing Chronic Obstructive Pulmonary Disease (COPD) isn’t just about taking medications—it’s about building a care team, fostering understanding, and creating routines that ...
Pharmacologic management of chronic obstructive pulmonary disease (COPD) centers on the use of inhaled bronchodilators and occasionally corticosteroids, delivered primarily ...
Chronic Obstructive Pulmonary Disease (COPD) is a major public health challenge, affecting millions of people worldwide. According to Ford et al. (2013), COPD is a leading cause ...
RECENT POSTS
January 15, 2026
December 2, 2025